Institution
University of California, Irvine
Also known as: UC Irvine · Universidad de California en Irvine · Université de Californie à Irvine · UCI
- 176running trials
- 81closed trials
- 203,466publications (OpenAlex)
Running trials
Not yet recruiting
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
Not yet recruiting
Self-administered Acupressure in Patients With Sickle Cell Disease
Not yet recruiting
Recruiting
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Recruiting
A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE
Not yet recruiting
Recruiting
Recruiting
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Recruiting
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
Recruiting
Recruiting
Recruiting
Recruiting
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Recruiting
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
Recruiting
Recruiting
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Recruiting
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
Recruiting
Showing 50 of 176.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer6 recruiting
- Acute myeloid leukaemia4 recruiting
- Alopecia areata4 recruiting
- Dermatomyositis and polymyositis (myositis)4 recruiting
- Epilepsy4 recruiting
- Obesity4 recruiting
- Sickle cell disease4 recruiting
- Stroke4 recruiting
- Type 2 diabetes4 recruiting
- Alzheimer disease3 recruiting
- Frontotemporal dementia3 recruiting
- Heart failure3 recruiting
- Lupus (SLE)3 recruiting
- Myasthenia gravis3 recruiting
- Parkinson disease3 recruiting
- ALS (motor neurone disease)2 recruiting
- Bladder cancer2 recruiting
- Chronic kidney disease2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Gastric and oesophageal cancer2 recruiting
- High blood pressure2 recruiting
- Liver and biliary tract cancer2 recruiting
- Melanoma2 recruiting
- Mild cognitive impairment2 recruiting
- Multiple myeloma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Pompe disease2 recruiting
- Prostate cancer2 recruiting
- Schizophrenia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- ANCA-associated vasculitis1 recruiting
- Antiphospholipid syndrome1 recruiting
- Aortic aneurysm1 recruiting
- Autism1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Cystic fibrosis1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Down syndrome1 recruiting
- Fibromyalgia1 recruiting
- Glioblastoma1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- Head and neck cancer1 recruiting
- Hodgkin lymphoma1 recruiting
- Huntington's disease1 recruiting
- Hypothyroidism1 recruiting
- IgA nephropathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Macular degeneration1 recruiting
- Meningioma1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Testicular cancer1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Terminated
Completed
Completed
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer
Recruiting
Terminated
Completed
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Completed
Completed
Comparing Different Rehabilitation Exercise Strategies for Improving Arm Recovery After Stroke
Completed
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
Terminated
Completed
Terminated
Completed
Completed
Terminated
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
Completed
Completed
Completed
Completed
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Terminated
Completed
Completed
SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer
Completed
Completed
Terminated
Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Terminated
Completed
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Completed
Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
Completed
Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
Completed
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
Completed
Completed
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies
Completed
Terminated
Completed
Completed
Completed
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Terminated
Completed
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Completed
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Terminated
Completed
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Completed
Completed
Exploring Outcomes and Characteristics of Myasthenia Gravis 2
Completed
Completed
Withdrawn
Showing 50 of 81.
Registry name variants (32)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University of California Irvine
Orange, California 92868
112 trials
University of California, Irvine
Irvine, California 92686
101 trials
UC Irvine
Orange, California 92868
7 trials
UC Irvine
Irvine, California 92697
6 trials
University of California at Irvine
Orange, California 92868
2 trials
University of California Irvine (Site 0029)
Orange, California 92868
2 trials
University of California Irvine (Site 1086)
Orange, California 92868
2 trials
The PREVENT Lab, University of California, Irvine
Irvine, California 92617
1 trial
NCT05558332Youth Nominated Support Team
UC Irvine, Department of Neurology
Orange, California 92868
1 trial
UC Irvine
Orange, California 92868
1 trial
UC Irvine
Orange, California 92868
1 trial
University California - Irvine
Orange, California 92868
1 trial
University California Irvine
Irvine, California 92697
1 trial
University of California at Irvine
Irvine, California 92617
1 trial
NCT06552728The Effects of Energy Healing in Fibromyalgia
Contact: Richard Harris, PhD
University of California at Irvine (Site 101)
Orange, California 92868
1 trial
University of California Irvine
Brisbane, California 94005
1 trial
University of California Irvine
Columbia, Maryland 21044
1 trial
University of California Irvine College of Medicine
Orange, California 92868
1 trial
University of California, Irvine: Department of Dermatology
Irvine, California 92697
1 trial
NCT04338581Evaluation of AMG 714 for Vitiligo
University of California Irvine, Department of Neurology
Orange, California 92868
1 trial
University of California, Irvine - Health Neurology Services
Orange, California 92868
1 trial
NCT05667142A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Contact: Xenon Medical Affairs
University of California Irvine
Irvine, California 92697-1385
1 trial
University of California Irvine
Irvine, California 92697-1385
1 trial
University of California Irvine
Irvine, California 92697-1385
1 trial
University of California Irvine
Irvine, California 92697-1385
1 trial
University of California Irvine - School of Medicine- Site Number : 8400143
Irvine, California 92697
1 trial
University of California Irvine - School of Medicine- Site Number : 8401143
Irvine, California 92697
1 trial
University of California Irvine Site Number : 8400002
Orange, California 92868
1 trial
University of California Irvine Site Number : 8400012
Orange, California 92868
1 trial
Univ. of California - Irvine
Irvine, California 92697
1 trial
Univ. of California - Irvine
Orange, California 92868
1 trial
Univ of California, Irvine, Dermatology Clinical Research Center
Irvine, California 92697
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Alzheimer disease318 works · 8 trials
- Stroke134 works · 7 trials
- Lung cancer100 works · 26 trials
- Down syndrome70 works · 2 trials
- Prostate cancer64 works · 8 trials
- Schizophrenia52 works · 4 trials
- Tuberculosis49 works · 0 trials
- Melanoma45 works · 6 trials
- Mild cognitive impairment40 works · 5 trials
- Ovarian cancer35 works · 2 trials
- Depression34 works · 0 trials
- Deep vein thrombosis and pulmonary embolism28 works · 2 trials
- Myasthenia gravis25 works · 11 trials
- Glaucoma24 works · 0 trials
- Migraine24 works · 0 trials
- Hearing loss21 works · 0 trials
- Acute myeloid leukaemia20 works · 8 trials
- Chronic lymphocytic leukaemia19 works · 4 trials
- Obstructive sleep apnoea19 works · 0 trials
- Spinal cord injury19 works · 1 trial
- Bipolar disorder18 works · 0 trials
- Alopecia areata18 works · 8 trials
- Sickle cell disease18 works · 8 trials
- Macular degeneration18 works · 1 trial
- ALS (motor neurone disease)17 works · 6 trials
- Childhood cancers16 works · 3 trials
- Neuroendocrine tumours15 works · 1 trial
- Pompe disease15 works · 5 trials
- Hodgkin lymphoma15 works · 2 trials
- Congenital heart disease14 works · 0 trials
Institution data: ROR 04gyf1771 (CC0-1.0)Updated 15 Nov 2026